Effect of the Test and Treat Strategy on Mortality Among HIV-Positive Adult Clients on Antiretroviral Treatment in Public Hospitals of Addis Ababa, Ethiopia

References

• Bendavid E, Brandeau ML, Wood R, Owens DK. Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med. 2010;170(15):1347–1354. doi:10.1001/archinternmed.2010.249
   Google Scholar
• WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection; 2016.
   Google Scholar
• World Health O. Progress Report 2016: Prevent HIV, Test and Treat All: WHO Support for Country Impact. Geneva: World Health Organization; 2016:2016.
   Google Scholar
• Office HPiERM-FHAPaC. HIV Prevention in EthiopiaNational Road Map 2018–2020; 2018.
   Google Scholar
• Girum T, Wasie A, Worku A. Trend of HIV/AIDS for the last 26 years and predicting achievement of the 90-90-90 HIV prevention targets by 2020 in Ethiopia: a time series analysis. BMC Infect Dis. 2018;18(1):320. doi:10.1186/s12879-018-3214-6
   Web of Science ®Google Scholar
• Central Statistical Agency Addis Ababa E. Demographic and Health Survey 2016; 2016.
   Google Scholar
• Tadesse K, Haile F, Hiruy N. FisahaHiruy, Neway. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. PLoS One. 2014;9(1):e87392–e87392. doi:10.1371/journal.pone.0087392
   PubMed Web of Science ®Google Scholar
• FMOH. List of Hospitals in Addis Ababa Ethiopia; 2017.
   Google Scholar
• Brinkhof MWG, Boulle A, Weigel R, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6(4):e1000066–e1000066. doi:10.1371/journal.pmed.1000066
   Web of Science ®Google Scholar
• Hambisa MT, Ali A, Dessie Y. Determinants of mortality among HIV positives after initiating antiretroviral therapy in Western Ethiopia: a Hospital-Based Retrospective Cohort Study. ISRN AIDS. 2013;2013:491601. doi:10.1155/2013/491601
   Google Scholar
• Kretzschmar ME, van der Loeff MF, Birrell PJ, De Angelis D, Coutinho RA. Prospects of elimination of HIV with test-and-treat strategy. Proc Natl Acad Sci U S A. 2013;110(39):15538–15543. doi:10.1073/pnas.1301801110
   Web of Science ®Google Scholar
• Walensky RP, David Paltiel A, Losina E, et al; Cepac Investigators. Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis. 2010;51(4):392–400. doi:10.1086/655130
   Web of Science ®Google Scholar
• Mengesha S, Belayihun B, Kumie A. Predictors of survival in HIV-infected patient after initiation of HAART in Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Int Sch Res Notices. 2014;2014:250913. doi:10.1155/2014/250913
   PubMedGoogle Scholar
• Angdembe MR, Rai A, Bam K, Pandey SR, Maiga AI. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: a retrospective cohort study, 2004–2013. PLoS One. 2019;14(4):e0215776. doi:10.1371/journal.pone.0215776
   PubMed Web of Science ®Google Scholar
• Belay H, Alemseged F, Angesom T, Hintsa S, Abay M. Effect of late HIV diagnosis on HIV-related mortality among adults in general hospitals of Central Zone Tigray, northern Ethiopia: a retrospective cohort study. HIV AIDS. 2017;9:187–192. doi:10.2147/HIV.S141895
   Google Scholar
• Ingabire PM, Semitala F, Kamya MR, Nakanjako D. Delayed Antiretroviral Therapy (ART) initiation among hospitalized adults in a resource-limited settings: a challenge to the global target of ART for 90% of HIV-infected individuals. AIDS Res Treat. 2019;2019:1832152. doi:10.1155/2019/1832152
   Web of Science ®Google Scholar
• Stafford KA, Odafe SF, Lo J, et al. Evaluation of the clinical outcomes of the test and treat strategy to implement treat all in Nigeria: results from the Nigeria multi-center ART Study. PLoS One. 2019;14(7):e0218555. doi:10.1371/journal.pone.0218555
   Web of Science ®Google Scholar
• Girum TY, Yasin F, Wasie A, et al. The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia. AIDS Res Ther. 2020;17(1):19. doi:10.1186/s12981-020-00274-3
   Web of Science ®Google Scholar
• Hazra A, Gogtay N. Biostatistics series module 9: survival analysis. Indian J Dermatol. 2017;62(3):251–257. doi:10.4103/ijd.IJD_85_17
   Web of Science ®Google Scholar
• Base K. How do the three methods compare to survival curves (log-rank, Mantel-Haenszel, Gehan-Breslow-Wilcoxon) differ? 2009; Available from: https://www.graphpad.com/support/faq/how-do-the-three-methods-compare-to-survival-curves-log-rank-mantel-haenszel-gehan-wilcoxon-differ/. Accessed March 19, 2021.
   Google Scholar
• Abebe NA, Alemu K, Asfaw T, Abajobir AA. Survival status of HIV positive adults on antiretroviral treatment in Debre Markos Referral Hospital, Northwest Ethiopia: retrospective cohort study. Pan Afr Med J. 2014;17:88. doi:10.11604/pamj.2014.17.88.3262
   Google Scholar
• Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther. 2012;9(1):15. doi:10.1186/1742-6405-9-15
   Web of Science ®Google Scholar
• Seyoum D, Degryse JM, Kifle YG, et al. Risk factors for mortality among adult HIV/AIDS patients following antiretroviral therapy in Southwestern Ethiopia: an assessment through survival models. Int J Environ Res Public Health. 2017;14(3):296. doi:10.3390/ijerph14030296
   PubMed Web of Science ®Google Scholar
• Damtew B, Mengistie B, Alemayehu T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr Med J. 2015;22:138. doi:10.11604/pamj.2015.22.138.4352
   PubMed Web of Science ®Google Scholar
• Duggal S, Chugh TD, Duggal AK. HIV and malnutrition: effects on immune system. Clin Dev Immunol. 2012;2012:784740. doi:10.1155/2012/784740
   PubMedGoogle Scholar
• Albrecht S, Franzeck FC, Mapesi H, et al; Kiularco Study Group. Age-related comorbidities and mortality in people living with HIV in rural Tanzania. AIDS. 2019;33(6):1031–1041. doi:10.1097/QAD.0000000000002171
   PubMed Web of Science ®Google Scholar
• Lorenc A, Ananthavarathan P, Lorigan J, Jowata M, Brook G. The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough. London J Prim Care. 2014;6(4):84–90. doi:10.1080/17571472.2014.11493422
   PubMedGoogle Scholar
• PEPFAR U, ICAP. Considerations for the Introduction of TLD in National Programs: PEPFAR Guidance on Developing Clinical and Programmatic Recommendations; 2018.
   Google Scholar